Moderna, Inc. 8-K Filing: Key Insights and Corporate Updates
Here are the key insights extracted from the provided section of the financial report:
- Entity Information:
- Company Name: Moderna, Inc.
- State of Incorporation: Delaware (DE)
- CIK Number: 0001682852
- SEC File Number: 001-38753
- Employer Identification Number (EIN): 81-3467528
- Address: 325 Binney Street, Cambridge, MA 02142
- Phone Number: 617-714-6500
- Filing Information:
- Filing Type: 8-K (a report of unscheduled material events or corporate changes)
- Filing Date: May 1, 2025
- Stock Information:
- Stock Type: Common stock
- Par Value: $0.0001 per share
- Ticker Symbol: MRNA
- Exchange: NASDAQ
- Period of Report:
- Report Date: May 1, 2025
Insights:
- The report indicates that Moderna, Inc. is engaged in activities that require disclosure due to an 8-K filing, which typically covers significant events that shareholders should be aware of.
- The company’s common stock is traded on NASDAQ under the ticker symbol MRNA, suggesting it is publicly traded and subject to SEC regulations.
- The specific date of the report indicates it may relate to events or changes occurring on that day, which could impact investors' decisions or the company's stock performance.
This information provides a foundational understanding of Moderna, Inc.'s current reporting status and corporate details as of the specified date.